Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Patient-Reported Outcomes in Virologically Suppressed, HIV-1–Infected Subjects After Switching to a Simplified, Single-Tablet Regimen of Efavirenz, Emtricitabine, and Tenofovir DF
2010
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients
2007
‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection
2016
Literacy, self-efficacy, and HIV medication adherence
2006
Prevalence of Herpes Simplex Virus Type 2 Infection, Human Immunodeficiency Virus/Herpes Simplex Virus Type 2 Coinfection, and Associated Risk Factors in a National, Population-Based Survey in Kenya
2011
Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults
2009
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
2007
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
2009 Standout
Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
2011
Factors Associated with the Emergence of K65R in Patients with HIV‐1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir
2008
Tenofovir como estrategia para evitar o detener efectos adversos
2008
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
2007
Ezetimibe Alone Reduces Low‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy
2008
HIV drug development: the next 25 years
2007
Greater Tenofovir‐Associated Renal Function Decline with Protease Inhibitor–Based versus Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy
2007
National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral‐naïve patients
2007
Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain
2004
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
2007
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
2009
Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
2009
HIV prevention among youth: A randomized controlled trial of voluntary counseling and testing for HIV and male condom distribution in rural Kenya
2019 StandoutNobel
Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
2009
Chronic kidney disease
2011 Standout
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance
2006
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Treatment for Adult HIV Infection
2006
The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAART on Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study
2010
Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men
2012
High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
2009
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
2006
Essential oils from aromatic herbs as antimicrobial agents
2011 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Durability and Outcome of Initial Antiretroviral Treatments Received during 2000–2005 by Patients in the Swiss HIV Cohort Study
2008
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review
2009
Early Predictors of Mortality from Pneumocystis jirovecii Pneumonia in HIV-Infected Patients: 1985-2006
2008
Pseudomonas Skin Infection
2011
How were new medicines discovered?
2011 Standout
Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
2010
Renal function with use of a tenofovir-containing initial antiretroviral regimen
2009
Literacy, Social Stigma, and HIV Medication Adherence
2008
Initiating Therapy: When to Start, What to Use
2008
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years
2007
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis
2009
Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir or Efavirenz or Both Plus Dual Nucleosides
2007
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
2006
Dancing with chemical formulae of antivirals: A panoramic view (Part 2)
2013
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study
2007
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?
2014
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results
2013
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
2009
Health Literacy
2007
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients
2008
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome
2006
Acyclic nucleoside phosphonates: Past, present and future
2006
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Industry sponsorship and research outcome
2012 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Nontuberculous Mycobacteria
1999
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Design Issues in Initial HIV-Treatment Trials: Focus on Actg A5095
2006
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Pathogenesis of Group A Streptococcal Infections
2000 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
The Connection Between Art, Healing, and Public Health: A Review of Current Literature
2009 Standout
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci
1996
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study
2014
Finding the Words to Say It: The Healing Power of Poetry
2005
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
2009
Low Health Literacy and Health Outcomes: An Updated Systematic Review
2011 Standout
Interventions for enhancing medication adherence
2014 Standout
Tailoring the volatility and stability of oligopeptides
2017 StandoutNobel
Review article: long‐term safety of nucleoside and nucleotide analogues in HBV ‐monoinfected patients
2016
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals
2010
Emtricitabine Prodrugs with Improved Anti-HIV Activity and Cellular Uptake
2012
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
2009
Hidden Killers: Human Fungal Infections
2012 Standout
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Guidelines for the management of hemophilia
2012 Standout
Incidence and Clinical Implications of Isolation of Mycobacterium kansasii: Results of a 5-Year, Population-Based Study
1998
Industry sponsorship and research outcome
2017 Standout
Clinical Implications of Mycobacterium kansasii Species Heterogeneity: Swiss National Survey
2003
Works of Rafael Campo being referenced
Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study
2013
Differences in Presentation and Outcome of Invasive Pneumococcal Disease among Patients with and without HIV Infection in the Pre-HAART Era
2005
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients
2006
Subcutaneous Nodules as a Dermatologic Manifestation of Bacteremia Due to Pseudomonas aeruginosa
1994
M Proteins Of Group G Streptococci: Mechanisms Of Resistance To Phagocytosis
1995
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
2006
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era
2001
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients
2008
Mycobacterium kansasiiDisease in Patients Infected with Human Immunodeficiency Virus
1997
Fulminant hepatitis from herpes simplex virus type 2 in an immunocompetent adult
2007
The Poetry of Healing: A Doctor's Education in Empathy, Identity, and Desire
1997